Filings under TIL by Trans-India Acquisition Corp (CIK 0001370433) from Feb 14, 2007 to Mar 13, 2007 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Matcham George | Director | Grant(A) | 7K | — | $0 |
| Jun 11, 2026 | Gibson Neil W | Director | Grant(A) | 0 | — | $0 |
| Jun 11, 2026 | Binder Gwendolyn | Director | Grant(A) | 7K | — | $0 |
| Jun 11, 2026 | McGaughy R Kent Jr | Director | Grant(A) | 7K | — | $0 |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Option exercise(M) | 17K | $11.60 | $197K |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Option exercise(M) | 13K | $12.68 | $165K |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Sell(S) | 12K | $23.88 | $298K |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Sell(S) | 18K | $23.04 | $404K |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Option exercise(M) | 13K | — | $0 |
| Sep 10, 2025 | Laumas Sandeep | CFO and CBO | Option exercise(M) | 17K | — | $0 |
| May 28, 2025 | McGaughy R Kent Jr | Director | Grant(A) | 7K | — | $0 |
| May 28, 2025 | Matcham George | Director | Grant(A) | 7K | — | $0 |
| May 28, 2025 | Gibson Neil W | Director | Grant(A) | 7K | — | $0 |
| May 28, 2025 | Binder Gwendolyn | Director | Grant(A) | 7K | — | $0 |
| Apr 25, 2025 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 105K | — | $0 |
| Apr 25, 2025 | Laumas Sandeep | CFO and CBO | Grant(A) | 45K | — | $0 |
| Sep 18, 2024 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 50K | — | $0 |
| Sep 18, 2024 | Laumas Sandeep | CFO and CBO | Grant(A) | 45K | — | $0 |
| Jun 13, 2024 | Gibson Neil W | Director | Grant(A) | 5K | — | $0 |
| Jun 13, 2024 | McGaughy R Kent Jr | Director | Grant(A) | 5K | — | $0 |
| Jun 13, 2024 | Binder Gwendolyn | Director | Grant(A) | 5K | — | $0 |
| Jun 13, 2024 | Matcham George | Director | Grant(A) | 5K | — | $0 |
| Feb 10, 2024 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 120K | — | $0 |
| Feb 10, 2024 | Laumas Sandeep | CFO and CBO | Grant(A) | 80K | — | $0 |
| Jun 14, 2023 | Nielsen Jack | Director | Grant(A) | 2K | — | $0 |
| Jun 14, 2023 | Matcham George | Director | Grant(A) | 2K | — | $0 |
| Jun 14, 2023 | Gibson Neil W | Director | Grant(A) | 2K | — | $0 |
| Jun 14, 2023 | McGaughy R Kent Jr | Director | Grant(A) | 2K | — | $0 |
| Jun 14, 2023 | Binder Gwendolyn | Director | Grant(A) | 2K | — | $0 |
| Jan 18, 2023 | Ray Sumita | Chief Legal and Admin Officer | Grant(A) | 50K | — | $0 |
| Jan 8, 2023 | Ray Sumita | Chief Legal and Admin Officer | Grant(A) | 415K | — | $0 |
| Jan 8, 2023 | Laumas Sandeep | CFO and CBO | Grant(A) | 415K | — | $0 |
| Jan 8, 2023 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 1.0M | — | $0 |
| Sep 6, 2022 | Moore Timothy L. | Chief Operating Officer | Grant(A) | 750K | — | $0 |
| May 20, 2022 | Matcham George | Director | Grant(A) | 30K | — | $0 |
| May 20, 2022 | McGaughy R Kent Jr | Director | Grant(A) | 30K | — | $0 |
| May 20, 2022 | Binder Gwendolyn | Director | Grant(A) | 30K | — | $0 |
| May 20, 2022 | Nielsen Jack | Director | Grant(A) | 30K | — | $0 |
| May 20, 2022 | Gibson Neil W | Director | Grant(A) | 30K | — | $0 |
| May 20, 2022 | Chiruvolu Vijay | Chief Technical Officer | Grant(A) | 154K | — | $0 |
| Mar 15, 2022 | McGaughy R Kent Jr | Director | Other(J) | 260K | — | $0 |
| Mar 4, 2022 | Laumas Sandeep | CFO and CBO | Grant(A) | 234K | — | $0 |
| Mar 4, 2022 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 750K | — | $0 |
| Mar 4, 2022 | Chiruvolu Vijay | Chief Technical Officer | Grant(A) | 257K | $8.62 | $2.2M |
| Mar 4, 2022 | Roberts Zachary | Chief Medical Officer | Grant(A) | 245K | $8.62 | $2.1M |
| Oct 7, 2021 | Roberts Zachary | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Sep 10, 2021 | Roberts Zachary | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| May 11, 2021 | Laumas Sandeep | CFO and CBO | Grant(A) | 200K | — | $0 |
| May 11, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 750K | — | $0 |
| May 11, 2021 | Roberts Zachary | Chief Medical Officer | Grant(A) | 200K | — | $0 |
| May 11, 2021 | Chiruvolu Vijay | Chief Technical Officer | Grant(A) | 200K | — | $0 |
| Apr 30, 2021 | Chiruvolu Vijay | Chief Technical Officer | Grant(A) | 154K | — | $0 |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Buy(P) | 450K | $20.00 | $9.0M |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 1.4M | — | — |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 30.0M | — | — |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 6.1M | — | — |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 1.2M | — | $0 |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 25.0M | — | $0 |
| Mar 23, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Conversion(C) | 5.1M | — | $0 |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Buy(P) | 450K | $20.00 | $9.0M |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 30.0M | — | — |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 6.1M | — | — |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 1.4M | — | — |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 25.0M | — | $0 |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 5.1M | — | $0 |
| Mar 23, 2021 | Curative Ventures V LLC | 10% Owner | Conversion(C) | 1.2M | — | $0 |
| Mar 23, 2021 | McGaughy R Kent Jr | Director | Buy(P) | 450K | $20.00 | $9.0M |
| Mar 23, 2021 | McGaughy R Kent Jr | Director | Conversion(C) | 7.1M | — | — |
| Mar 23, 2021 | McGaughy R Kent Jr | Director | Conversion(C) | 954K | — | — |
| Mar 23, 2021 | McGaughy R Kent Jr | Director | Conversion(C) | 5.9M | — | $0 |
| Mar 23, 2021 | McGaughy R Kent Jr | Director | Conversion(C) | 795K | — | $0 |
| Mar 23, 2021 | Nielsen Jack | Director | Conversion(C) | 477K | — | — |
| Mar 23, 2021 | Nielsen Jack | Director | Buy(P) | 300K | $20.00 | $6.0M |
| Mar 23, 2021 | Nielsen Jack | Director | Conversion(C) | 11.7M | — | — |
| Mar 23, 2021 | Nielsen Jack | Director | Conversion(C) | 9.8M | — | $0 |
| Mar 23, 2021 | Nielsen Jack | Director | Conversion(C) | 398K | — | $0 |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 5.1M | — | — |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 510K | — | — |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 430K | — | — |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 43K | — | — |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 481K | — | — |
| Mar 23, 2021 | Shah Nimish P | Director | Buy(P) | 105K | $20.00 | $2.1M |
| Mar 23, 2021 | Shah Nimish P | Director | Buy(P) | 20K | $20.00 | $392K |
| Mar 23, 2021 | Shah Nimish P | Director | Buy(P) | 10K | $20.00 | $209K |
| Mar 23, 2021 | Shah Nimish P | Director | Buy(P) | 117K | $20.00 | $2.3M |
| Mar 23, 2021 | Shah Nimish P | Director | Buy(P) | 48K | $20.00 | $968K |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 36K | — | $0 |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 401K | — | $0 |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 4.3M | — | $0 |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 359K | — | $0 |
| Mar 23, 2021 | Shah Nimish P | Director | Conversion(C) | 425K | — | $0 |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Conversion(C) | 11.7M | — | — |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Conversion(C) | 477K | — | — |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Buy(P) | 300K | $20.00 | $6.0M |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Conversion(C) | 398K | — | $0 |
| Mar 23, 2021 | Vivo Capital Fund IX, L.P. | 10% Owner | Conversion(C) | 9.8M | — | $0 |
| Mar 18, 2021 | Binder Gwendolyn | Director | Grant(A) | 52K | — | $0 |
| Mar 18, 2021 | Chiruvolu Vijay | Chief Technical Officer | Grant(A) | 240K | — | $0 |
| Mar 18, 2021 | Crouch Bronson | CEO and Chairman, Director, 10% Owner | Grant(A) | 1.2M | — | $0 |
| Mar 18, 2021 | Gibson Neil W | Director | Grant(A) | 52K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Instil Bio, Inc., SEC CIK 0001789769. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TIL and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for TIL